Fate Therapeutics Inc (FATE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fate Therapeutics Inc   (NASDAQ: FATE)


Fate Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fate Therapeutics Inc's ROI in the second quarter of 2026?
Fate Therapeutics Inc recorded a cumulative net loss of $-126 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -59.4%.

Within the Healthcare sector 268 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3706 to 3765.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -31.07 % -35.43 % -34.11 % -29.04 % -22.8 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 228 180 207 234 261
Return On Investment (TTM) -59.4 % -58.89 % -55.02 % -56.63 % -55.74 %
FATE's Overall Ranking # 3765 # 3706 # 3411 # 3236 # 3085
Seq. Investment Change TTM -3.84 % -10.97 % -10.12 % -10.42 % -9.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -126 -130 -136 -156 -172

FATE Company Profile >> Back to FATE Roi Comparisons >> See Annual FATE Return On Investment



Return On Investment FATE's Ranking
Within: No.
Industry # 35
Sector # 269
Overall # 3765

Return On Investment Statistics
High Average Low
-22.7 %
-48.76 %
-78.67 %
(Dec 31 2021)   (Sep 30 2016)







Financial Statements
Fate Therapeutics Inc's II. Quarter Investments $ 228 Millions FATE's Balance sheet
Fate Therapeutics Inc's II. Quarter Income $ -30 Millions Quarterly FATE's Income Statement
FATE's Income by Division See FATE's Income by Division


FATE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 207 319 368 484 840
Y / Y Investment Growth -35 % -13.49 % -23.87 % -42.4 % 56.49 %
Net Income in Millions -136 -186 -161 -282 -212
Y / Y Net Income Growth - - - - -
Annual Return On Investment -65.79 % -58.44 % -43.68 % -58.21 % -25.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FATE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FATE's Competitors
Subscribers only: Roi for Fate Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FATE's Customers

Other Ratios
FATE's Roa FATE's Inventory Turnover Ratio FATE's Growth Rates FATE's Dividend Statistics
FATE's Profitability Ratios FATE's Asset Turnover Ratio FATE's Dividend Growth
FATE's Roe FATE's Valuation Ratios FATE's Financial Strength Ratios FATE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:14:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.